Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
(Array)CGH analysis of chromosomal gains and losses in human malignant pleural mesothelioma cell lines: Involved loci and genes Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features Source: Eur Respir J 2006; 28: Suppl. 50, 335s Year: 2006
Genetic and epigenetic analysis of the 17q12-21 locus in the Saguenay–Lac-Saint-Jean (SLSJ) asthma familial cohort. Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Genetics, pathology, and therapy of neuroendocrine tumours of the lung Source: International Congress 2017 – ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung Year: 2017
Non-random chromosomal breakpoints and genetic predisposition to nonsmall cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Asbestos-related lung cancers are rarely associated with ALK , ROS1 and RET rearrangements Source: Eur Respir J, 51 (3) 1702605; 10.1183/13993003.02605-2017 Year: 2018
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype Source: Eur Respir J 2014; 43: 872-883 Year: 2014
Multiple primary malignancies involving lung: an analysis of 40 cases Source: Eur Respir J 2006; 28: Suppl. 50, 127s Year: 2006
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005
Expression of D2-40 in small cell lung carcinomas (SCLC); Association with lymphatic invasion(L.I), clinical parameters and prognosis Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004
Comparing LYVE-1 and D2-40 expression in small cell lung carcinomas (SCLC); association with clinical parameters and lymphatic invasion Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Tumoural tissue specific promoter hypermethylation of distinct tumour suppressor genes in a case with nonsmall cell lung carcinoma: a case report Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009
Croatian Caucasians with lung adenocarcinoma harbouring EGFR mutations with and without brain metastasis Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Genetic alterations in early sage of pulmonary large cell neuroendocrine carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
LSC - 2017 - KRAS & TP53 mutations cause malignant mesothelioma Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017